Opko Health (OPK) Non Operating Interest Expenses (2011 - 2026)
Opko Health's (OPK) quarterly Non Operating Interest Expenses came in at $11.4 million in Q2 2026, down 83.82% on a YoY basis from $70.3 million in Q2 2025, and up 4.03% quarter-over-quarter from $10.9 million in Q1 2026.
Opko Health (OPK) Non Operating Interest Expenses (2011 - 2026) Analysis & Trends
Opko Health (OPK) has reported Non Operating Interest Expenses for 16 consecutive years, with $11.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 83.82% year-over-year to $11.4 million; the trailing twelve-month figure through Jun 2026 stood at $45.0 million (down 66.65% YoY), and the FY2025 full-year result was $108.5 million, up 128.51% from the prior year.
- Non Operating Interest Expenses rose to $11.4 million in Q2 2026 per OPK's latest filing, from $10.9 million in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $70.3 million in Q2 2025 and bottomed at $2.7 million in Q1 2022.
- Historically, Non Operating Interest Expenses has averaged $12.5 million across 5 years, with a median of $7.7 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Non Operating Interest Expenses jumped 881.83% in 2024, then slumped 83.82% in 2026.
- Over 5 years, Non Operating Interest Expenses stood at $3.3 million in 2022, then climbed by 4.57% to $3.5 million in 2023, then surged by 862.21% to $33.2 million in 2024, then slumped by 65.96% to $11.3 million in 2025, then advanced by 0.62% to $11.4 million in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $11.4 million, $10.9 million, and $11.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | -333.60 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 23.78 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 39.74 Mn |
| 10 | Opko Health | 1.25 Bn | 945.61 Mn | 80.02 Mn | 11.38 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.38 Mn |
| Mar 31, 2026 | 10.94 Mn |
| Dec 31, 2025 | 11.31 Mn |
| Sep 30, 2025 | 11.36 Mn |
| Jun 30, 2025 | 70.33 Mn |
| Mar 31, 2025 | 15.47 Mn |
| Sep 30, 2024 | 33.23 Mn |
| Jun 30, 2024 | 15.87 Mn |
| Mar 31, 2024 | 7.69 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.28 Mn |
| Mar 31, 2023 | 3.39 Mn |
| Dec 31, 2022 | 3.30 Mn |
| Sep 30, 2022 | 3.02 Mn |
| Jun 30, 2022 | 3.08 Mn |
| Mar 31, 2022 | 2.66 Mn |
| Dec 31, 2021 | 4.31 Mn |
| Sep 30, 2021 | 4.29 Mn |
| Jun 30, 2021 | 4.89 Mn |
Opko Health Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OPK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();